Jane Street
MTNB icon

Jane Street’s Matinas BioPharma MTNB Stock Holding History

Jane Street’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,899
Closed -$9.32K – 12486
2025
Q4 		$9.32K Buy
+15,899
New +$18.7K ﹤0.01% 10848
2024
Q3 		– Sell
-2,068
Closed -$16.1K – 10109
2024
Q2 		$16.1K Buy
+2,068
New +$18.7K ﹤0.01% 9059
2023
Q4 		– Sell
-690
Closed -$4.49K – 9586
2023
Q3 		$4.49K Buy
+690
New +$8.47K ﹤0.01% 8450
2023
Q2 		– Sell
-1,159
Closed -$27.2K – 9250
2023
Q1 		$27.2K Sell
1,159
-2,943
-72% -$74.4K ﹤0.01% 8590
2022
Q4 		$103K Buy
4,102
+1,430
+54% +$47.6K ﹤0.01% 8076
2022
Q3 		$85K Sell
2,672
-583
-18% -$22.9K ﹤0.01% 8730
2022
Q2 		$129K Buy
3,255
+2,945
+950% +$112K ﹤0.01% 8505
2022
Q1 		$12K Buy
+310
New +$11.4K ﹤0.01% 10041
2021
Q4 		– Sell
-3,243
Closed -$211K – 10567
2021
Q3 		$211K Buy
3,243
+2,757
+567% +$119K ﹤0.01% 8763
2021
Q2 		$19K Buy
486
+14
+3% +$602 ﹤0.01% 9643
2021
Q1 		$25K Sell
472
-36
-7% -$2.42K ﹤0.01% 8951
2020
Q4 		$35K Buy
+508
New +$23.5K ﹤0.01% 7349
2020
Q3 		– Sell
-5,158
Closed -$199K – 7640
2020
Q2 		$199K Buy
5,158
+813
+19% +$31.2K ﹤0.01% 6379
2020
Q1 		$130K Buy
+4,345
New +$262K ﹤0.01% 4830
2019
Q3 		– Sell
-732
Closed -$31K – 5512
2019
Q2 		$31K Sell
732
-97
-12% -$4.66K ﹤0.01% 4995
2019
Q1 		$45K Buy
829
+543
+190% +$29.2K ﹤0.01% 4838
2018
Q4 		$9K Buy
+286
New +$11.2K ﹤0.01% 4828
2018
Q3 		– Sell
-552
Closed -$12K – 5491
2018
Q2 		$12K Buy
+552
New +$15.9K ﹤0.01% 4879

Other funds holding MTNB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street's MTNB Position: Q1 2026 in Review

Jane Street sold out of Matinas BioPharma (MTNB) in Q1 2026, closing a stake of 15,899 shares — an estimated $9.32K sold.

Jane Street first reported a position in MTNB in Q2 2018 and held it in 18 quarters. The position peaked at $211K in Q3 2021. 28 funds tracked by Wall St. Rank hold MTNB as of Q1 2026.

  • Jane Street reported no remaining Matinas BioPharma position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 15,899 Matinas BioPharma shares in Q1 2026, an estimated $9.32K.
  • Jane Street first reported a position in Matinas BioPharma in Q2 2018 and held it in 18 quarters.
  • Jane Street's Matinas BioPharma position peaked at $211K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.